Open-label phase 1 study evaluating the tolerability and anti-tumor activity of selinexor and pembrolizumab in colorectal cancer.Talia Golan,Talia Shentzer Kutiel,Ravit Geva,Maya Gottfried,Aviad Zick, Julia Dudnik, Einat Netiv,Yue Zhang,Fan Yang,Shmuel Sharoni, J. Paul Duic,Changting Meng, Dayana Michel,Jatin J. Shah,Michael G. Kauffman, Sharon Shacham,Alona ZerJOURNAL OF CLINICAL ONCOLOGY(2021)引用 1|浏览13暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要